1. General introduction 27 1. REFERENCES 1. Rockwell WB, Cohen IK, Ehrlich HP. Keloids and hypertrophic scars: a comprehensive review. Plast Reconstr Surg. Nov 1989;84(5):827-37. doi:10.1097/00006534198911000-00021 2. Sitaniya S, Subramani D, Jadhav A, Sharma YK, Deora MS, Gupta A. Quality-of-life of people with keloids and its correlation with clinical severity and demographic profiles. Wound Repair Regen. May 2022;30(3):409-416. doi:10.1111/wrr.13015 3. Balci DD, Inandi T, Dogramaci CA, Celik E. DLQI scores in patients with keloids and hypertrophic scars: a prospective case control study. J Dtsch Dermatol Ges. Aug 2009;7(8):688-92. doi:DDG07034 [pii] 10.1111/j.1610-0387.2009.07034.x 4. McGinty S, Siddiqui WJ. Keloid. Jan 2023;doi:NBK507899 [bookaccession] 5. Wallace HA, Basehore BM, Zito PM. Wound Healing Phases. Jan 2023;doi:NBK470443 [bookaccession] 6. Berman B, Maderal A, Raphael B. Keloids and Hypertrophic Scars: Pathophysiology, Classification, and Treatment. Dermatologic Surgery. 2017;43:S3-S18. doi:10.1097/dss.0000000000000819 7. Orenius T, LicPsych, Saila H, Mikola K, Ristolainen L. Fear of Injections and Needle Phobia Among Children and Adolescents: An Overview of Psychological, Behavioral, and Contextual Factors. SAGE Open Nurs. Jan-Dec 2018;4:2377960818759442. doi:10.1177_2377960818759442 [pii] 10.1177/2377960818759442 8. Jiao H, Fan J, Cai J, et al. Analysis of Characteristics Similar to Autoimmune Disease in Keloid Patients. Aesthetic Plast Surg. Oct 2015;39(5):818-25. doi:10.1007/s00266-0150542-4 9. Liu R, Xiao H, Wang R, et al. Risk factors associated with the progression from keloids to severe keloids. Chin Med J (Engl). Apr 5 2022;135(7):828-836. doi:00029330202204050-00012 [pii] CMJ-2021-2354 [pii] 1097/CM9.0000000000002093 10. Alster TS, Tanzi EL. Hypertrophic scars and keloids: etiology and management. Am J Clin Dermatol. 2003;4(4):235-43. doi:443 [pii] 10.2165/00128071-200304040-00003
RkJQdWJsaXNoZXIy MTk4NDMw